Prescient Therapeutics Ltd has released a press release.
Prescient Receives $1.03m R&D Tax Rebate
Filed with ASX ·
6ix hasn’t read this filing yet.
Prescient Therapeutics Limited on 6ix
Story so far
Earlier from Prescient Therapeutics
- September 2020 Quarterly Update and Appendix 4C
- Response to ASX Query
- PTX Raises $7 million via Strongly Supported Placement
- Appendix 4E and 2020 Annual Report
- Successful SPP Closed Early
Later from Prescient Therapeutics
- PTX announces 3 next-gen CAR-T programs with OmniCAR
- December 2020 Quarterly Update and Appendix 4C
- PTX-200 AML Trial Progresses to Higher Dose
- March 2021 Quarterly Update and Appendix 4C
- PTX signs CAR-T agreement with Peter MacCallum
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics